Statins Ticagrelor and Rhabdomyolysis: A Coincidence or a Drug Interaction?
Ramesh PatelJai Bharat SharmaSaraswati RajputPublished in: Journal of lipid and atherosclerosis (2023)
The concomitant use of ticagrelor and high-intensity statins should be carefully considered due to the additional risk of rhabdomyolysis and kidney injury. Future pharmacokinetic studies are needed to establish a causal relationship and predict potential drug interactions, which, if not avoided, could be fatal.
Keyphrases
- high intensity
- acute kidney injury
- acute coronary syndrome
- percutaneous coronary intervention
- cardiovascular disease
- st elevation myocardial infarction
- antiplatelet therapy
- st segment elevation myocardial infarction
- resistance training
- current status
- coronary artery disease
- case control
- emergency department
- atrial fibrillation
- adverse drug
- body composition
- drug induced
- risk assessment